Protective factors can mitigate behavior problems after prenatal cocaine and other drug exposures

Henrietta S Bada1, Carla M Bann, Toni M Whitaker

  • 1Department of Pediatrics, College of Medicine, University of Kentucky, Lexington, KY 40536, USA. hbada2@uky.edu

Pediatrics
|November 28, 2012
PubMed

Insights

High prenatal cocaine exposure (PCE) and other drug use significantly increases adolescent behavior problems. Protective factors can mitigate these risks, highlighting the need for supportive interventions for drug-exposed children.

Area of Science:

  • Developmental Psychology
  • Neuroscience
  • Public Health

Background:

  • Investigating the long-term behavioral effects of prenatal drug exposure, specifically high prenatal cocaine exposure (PCE) combined with other drug (OD) use.
  • Examining the interplay of individual, family, and community risk and protective factors on developmental trajectories.

Purpose of the Study:

  • To determine the role of risk and protective factors on behavior problem trajectories in children with high PCE/polydrug exposure.
  • To analyze the impact of different levels of prenatal drug exposure on behavioral outcomes through adolescence.

Main Methods:

  • Longitudinal study of 1388 children assessed up to age 15, categorizing prenatal exposure into high PCE/OD, some PCE/OD, OD/no PCE, and no PCE/no OD.
  • Utilized latent growth curve models to assess trajectories of externalizing, internalizing, total behavior, and attention problems.
  • Examined risk and protective factors at individual, family, and community levels, employing stepwise analysis and cumulative indexes.

Main Results:

  • High PCE/OD significantly predicted externalizing, total behavior, and attention problems.
  • Some PCE/OD predicted externalizing and attention problems; OD/no PCE predicted most behavior outcomes except internalizing behavior.
  • A high level of protective factors was associated with declining problem behavior scores over time, irrespective of drug exposure or risk levels.

Conclusions:

  • High PCE/OD poses a significant risk for adolescent behavior problems, but protective factors can lessen these adverse effects.
  • Clinical practice and public health initiatives should focus on bolstering protective factors and reducing risks for drug-exposed children to improve long-term outcomes.
Abstract

Related Concept Videos

Drug Toxicity: Risk factors01:24

Drug Toxicity: Risk factors

Adverse Drug Reactions (ADRs) are potential complications that arise during pharmacotherapy, influenced by multiple risk factors. Age plays a significant role; both neonates and the elderly are at heightened risk due to their respective immature and diminished metabolic and elimination processes. Gender also impacts ADRs, with females experiencing a 1.5 to 1.7-fold greater risk than males, which may be linked to pharmacokinetic, pharmacodynamic, and hormonal differences. Notably, neonates, the...
Attention-Deficit/Hyperactivity Disorder01:30

Attention-Deficit/Hyperactivity Disorder

Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by persistent inattention, hyperactivity, and impulsivity. It affects approximately 5-8% of children globally, with around 60-70% of cases persisting into adulthood. ADHD has significant implications for educational attainment, social interactions, and occupational success.
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings.
Factors Affecting Drug Response: Overview01:21

Factors Affecting Drug Response: Overview

When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
Operant Conditioning Intervention01:24

Operant Conditioning Intervention

Operant conditioning serves as a foundational principle in therapeutic interventions aimed at modifying maladaptive behaviors. Central to this approach is the notion that behaviors, both adaptive and maladaptive, are learned through reinforcement. By analyzing the environmental factors that reinforce problematic behaviors, clinicians can design interventions to weaken these reinforcements and replace maladaptive behaviors with healthier alternatives.
In operant conditioning, behaviors that are...
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics01:23

Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics

Respiratory symptoms, such as congestion and cough, commonly accompany respiratory tract conditions. Various medications, such as antitussives, expectorants, and mucolytics, play crucial roles in providing relief.
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla.  Benzonatate operates peripherally within the respiratory tract by anesthetizing...